Formulation Development Outsourcing Market by Product Type, Distribution Channel, End User 2023-2028

1
Global Formulation Development Outsourcing Market
Research and Forecast Report 2023-2028

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Formulation Development Outsourcing
  Market Global Industry Trends, Share, Size,
  Growth, Opportunity and Forecast
  2023-2028," the global formulation development
  outsourcing market size reached US 22.6 Billion
  in 2022.
• Formulation development involves creating and
  optimizing a formulation for a specific product
  or application. This process is particularly
  common in pharmaceuticals, cosmetics, food and
  beverages (FB), and agrochemical sectors, where
  the product's composition is critical to its
  effectiveness, stability, and overall
  performance. Formulation development outsourcing
  refers to the process in which pharmaceutical
  companies delegate the tasks of drug formulation
  and development to external service providers.
• These service providers are usually contract
  research organizations (CROs) or contract
  development and manufacturing organizations
  (CDMOs) with specialized expertise and advanced
  technological capabilities. Drug formulation
  involves the design and manufacture of a stable
  and effective pharmaceutical product,
  encompassing aspects such as dosage form,
  composition, taste, and shelf life. This process
  can be complex and resource-intensive, involving
  numerous stages like pre-formulation, prototype
  development, stability studies, scale-up, and
  process validation. By outsourcing formulation
  development, pharmaceutical companies can access
  specialized knowledge, mitigate risks, increase
  efficiency, reduce costs, and accelerate
  time-to-market.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/formulation-development
  -outsourcing-market/requestsample

4
Report Description

• Global Formulation Development Outsourcing Market
  Trends
• The increasing prevalence of chronic diseases,
  such as diabetes, COPD, cancer, asthma,
  arthritis, and Alzheimer's disease, that creates
  a pressing need for new and effective drugs to
  address these conditions is one of the major
  factors driving the market growth. Additionally,
  the growing demand for highly specialized
  knowledge and skills in various scientific
  disciplines, such as chemistry, pharmacy, food
  science, or cosmetic technology, and the
  expertise of specialized contract development
  organizations (CDOs) that have dedicated teams
  with extensive experience in formulating specific
  types of products are acting as other
  growth-inducing factors.
• Moreover, the rising popularity of outsourcing
  that provides companies with the flexibility to
  adapt to changing market demands and the need for
  the development of new products or adjustments in
  the existing formulations, allowing for quick
  access to additional resources without long-term
  commitments, is creating a positive outlook for
  the market. Additionally, the increasing
  utilization of outsourcing to CROs with
  established protocols and workflows, leading to
  faster and more cost-efficient development,
  helping companies save time and resources in
  bringing new drugs to market, is favoring the
  market growth. Besides this, the increasing need
  to innovate and develop novel medicines the
  replace the lost revenue caused due to patent
  expiration is providing remunerative growth
  opportunities.
• Looking forward, the market value is projected to
  reach US 33.7 Billion by 2028, expanding at a
  CAGR of 6.2 during 2023-2028.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/formulation-development
  -outsourcing-market

5
Report Segmentation

• Breakup by Service
• Pre-formulation Services
• Discovery and Preclinical Services
• Analytical Services
• Formulation Optimization
• Phase I
• Phase II
• Phase III
• Phase IV
• Breakup by Dosage Form
• Injectable
• Oral
• Topical
• Others

6
Report Segmentation

• Breakup by Application
• Oncology
• Genetic Disorders
• Neurology
• Infectious Diseases
• Respiratory
• Cardiovascular
• Others
• Breakup by End User
• Pharmaceutical and Biopharmaceutical Companies
• Government and Academic Institutes

7
Report Segmentation

• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

8
Competitive Landscape with Key Players

• Aizant Drug Research Solutions Private Limited
• Catalent Inc.
• Charles River Laboratories
• Dr. Reddys Laboratories Ltd.
• Emergent BioSolutions Inc.
• Intertek Group plc
• Irisys LLC (Recro Pharma)
• Laboratory Corporation of America Holdings
• Lonza Group AG
• Piramal Pharma Solutions
• Quotient Sciences
• Syngene International Limited (Biocon Limited)
• Thermo Fisher Scientific Inc.

9
Key Questions Answered in the Report
10
Key Questions Answered in the Report
11
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Formulation
  Development Outsourcing Market    5.1    Market
  Overview    5.2    Market Performance    5.3  
   Impact of COVID-19  5.4    Market Forecast
• 6     Market Breakup by Service
•   6.1    Pre-formulation Services    6.1.1
  Market Trends       6.1.2 Key Segments   
  6.1.2.1  Discovery and Preclinical Services     
    6.1.2.2 Analytical Services
•        6.1.3 Market Forecast
•   6.2    Formulation Optimization    6.2.1
  Market Trends       6.2.2 Key Segments       

12
Table of Contents

•     6.2.2.1  Phase I        6.2.2.2
  Phase II
•     6.2.2.3  Phase III        6.2.2.4
  Phase IV       6.2.3 Market Forecast
• 7  Market Breakup by Dosage Form
• 7.1 Injectable
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Oral
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Topical
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 7.4 Others
• 7.4.1 Market Trends
• 7.4.2 Market Forecast
• 8  Market Breakup by Application
• 8.1 Oncology
• 8.1.1 Market Trends
• 8.1.2 Market Forecast

13
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

14
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com